Melissa Burgess

University of Pittsburgh

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (10)

Karla Ballman

Chair / Consultant / Professor of Biostatistics

Mayo Clinic College of Medicine and Science

UNITED STATES

View details

Niels Junker

Chief Physician

DENMARK

View details

Anthony Cillo

Assistant Professor

University of Pittsburgh

UNITED STATES

View details

Claudia M Salgado

Assistant Professor

Children's Hospital of Pittsburgh of UPMC

UNITED STATES

View details

Shanthi Bhaskar

University of Pittsburgh

UNITED STATES

View details

Gabriel Tinoco

Assistant Professor of Medicine

Ohio State University

UNITED STATES

View details

Nathanael Bailey

Associate Professor

University of Pittsburgh

UNITED STATES

View details

Ivy John

UNITED STATES

View details

Dimitrios Korentzelos

Assistant Professor

UPMC Presbyterian

UNITED STATES

View details

Elizabeth Davis

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Melissa Burgess

Research Interests

Explore related searches

Contact this professor

Articles (7)

SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade Resistance

Malignant ossifying fibromyxoid tumour with TP53::PHF1 fusion: report of three cases suggesting an association between rare fusions and malignant phenotypes

<i>ALX4</i>::<i>NCOA2</i> rearranged round and spindle cell sarcoma

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Collaborators (10)

Karla Ballman

Niels Junker

Anthony Cillo

Claudia M Salgado

Shanthi Bhaskar

Gabriel Tinoco

Nathanael Bailey

Ivy John

Dimitrios Korentzelos

Elizabeth Davis

Make your next move.